-
2023-505500-37-00
5
Pregnant women with singleton pregnancies hospitalized for threatened
-
2023-506599-28-01
4
Fulminant myocarditis
-
2024-516257-44-00
4
Multiple myeloma
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
-
2024-519624-24-00
4
HER3-mutant and HER2-not amplified metastatic breast cancer
-
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
-
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
-
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
-
2025-521437-88-00
4
head and neck squamous cell carcinoma
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-523683-20-00
4
Postmenopausal patients with small (pT1a-b pN0) hormone receptor posit
-
2024-515181-14-00
5
2026-05-20
Patients with preoperative biliary stent treated by
pancreaticoduodene
-
2025-521711-39-00
5
2026-05-17
Lewy body Dementia psychosis (LBDP)
-
2025-522996-27-00
5
2026-05-05
recurrent and/or metastatic squamous cell carcinoma of the head and ne
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2024-512714-18-00
9
2025-11-11
Relapsing Multiple Sclerosis
-
2024-512926-27-00
5
2024-12-12
patients with estrogen receptor-positive/human epidermal growth factor
-
2023-504026-19-01
5
2024-06-05
Prostate Cancer
-
2024-518019-20-00
4
2021-10-19
La population concernée est celle des patients hospitalisés en réanima
-
2024-518195-31-00
6
2021-09-29
acute myocardial infarction
-
2023-506838-68-00
9
2020-12-10
Renal cell carcinoma